Clinical trial

PIK3CA Mutational Status Assessment

NCT06706570

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2024-11-06

PhaseN/A

Study timeline

Study start (actual)2024-11-06Date precision: day

Registry last updated2026-03-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer Metastaticunresolved

Interventions

Sponsors & collaborators

European Institute of Oncologylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06706570 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.